Maass M, Dalhoff K
Institute of Medical Microbiology, Medical University of Lübeck, Germany.
J Clin Microbiol. 1994 Oct;32(10):2616-9. doi: 10.1128/jcm.32.10.2616-2619.1994.
Amplification inhibitors can lead to false-negative results for PCR. In order to evaluate the reliability of PCR for the detection of Chlamydia pneumoniae, the presence of PCR inhibitors in 75 bronchoalveolar lavage specimens was assessed after treatment by various sample preparation methods. Specimens were collected from patients with acute respiratory infections, including four cases of proven C. pneumoniae infection. Substances inhibitory to the amplification of chlamydial DNA continued to be present in 12% of the samples treated according to the commonly used single-step proteinase K digestion and in 31% of the samples processed by heat treatment. However, the complexing of DNA-contaminating proteins and polysaccharides from digested specimens to cetyltrimethylammonium bromide (CTAB) followed by DNA extraction efficiently removed inhibitors from all experimental samples and provided subsequent identification of all positive clinical samples by PCR. The CTAB method and proteinase K treatment had comparable detection limits of approximately 0.01 inclusion-forming units. CTAB-based DNA purification of respiratory specimens is recommended to increase the diagnostic sensitivity of PCR and confidence in negative results.
扩增抑制剂可导致PCR出现假阴性结果。为评估PCR检测肺炎衣原体的可靠性,采用多种样本制备方法处理75份支气管肺泡灌洗标本后,评估其中PCR抑制剂的存在情况。标本取自急性呼吸道感染患者,包括4例确诊的肺炎衣原体感染病例。按照常用的单步蛋白酶K消化法处理的样本中,12%仍存在抑制衣原体DNA扩增的物质;经热处理的样本中,31%存在此类物质。然而,将消化标本中污染DNA的蛋白质和多糖与十六烷基三甲基溴化铵(CTAB)络合,随后进行DNA提取,可有效去除所有实验样本中的抑制剂,并通过PCR对所有阳性临床样本进行后续鉴定。CTAB法和蛋白酶K处理的检测限相当,约为0.01个包涵体形成单位。建议采用基于CTAB的呼吸道标本DNA纯化方法,以提高PCR的诊断敏感性和对阴性结果的可信度。